BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 38468490)

  • 1. [Not Available].
    Liu L; Chen Y; Zhang T; Cui G; Wang W; Zhang G; Li J; Zhang Y; Wang Y; Zou Y; Ren Z; Xue W; Sun R
    Adv Sci (Weinh); 2024 May; 11(20):e2302379. PubMed ID: 38566431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NSUN2 affects diabetic retinopathy progression by regulating MUC1 expression through RNA m
    Wang R; Xue W; Kan F; Zhang H; Wang D; Wang L; Wang J
    J Transl Med; 2024 May; 22(1):476. PubMed ID: 38764010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RNA Methyltransferase NSUN2 and Its Potential Roles in Cancer.
    Chellamuthu A; Gray SG
    Cells; 2020 Jul; 9(8):. PubMed ID: 32708015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization.
    Zou S; Huang Y; Yang Z; Zhang J; Meng M; Zhang Y; Feng J; Sun R; Li W; Wang W; López JG; Fang L
    Clin Transl Med; 2024 Mar; 14(3):e1621. PubMed ID: 38468490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Methylcytosine transferase NSUN2 drives NRF2-mediated ferroptosis resistance in non-small cell lung cancer.
    Chen Y; Jiang Z; Zhang C; Zhang L; Chen H; Xiao N; Bai L; Liu H; Wan J
    J Biol Chem; 2024 Apr; 300(4):106793. PubMed ID: 38403250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer.
    Wang Y; Wei J; Feng L; Li O; Huang L; Zhou S; Xu Y; An K; Zhang Y; Chen R; He L; Wang Q; Wang H; Du Y; Liu R; Huang C; Zhang X; Yang YG; Kan Q; Tian X
    Mol Cancer; 2023 May; 22(1):81. PubMed ID: 37161388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNHG14 promotes the tumorigenesis and metastasis of colorectal cancer through miR-32-5p/SKIL axis.
    Ye T; Zhang N; Wu W; Yang B; Wang J; Huang W; Tang D
    In Vitro Cell Dev Biol Anim; 2019 Dec; 55(10):812-820. PubMed ID: 31471872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m
    Du X; Cheng C; Yang Y; Fan B; Wang P; Xia H; Ni X; Liu Q; Lu L; Wei L
    Mol Carcinog; 2024 May; 63(5):962-976. PubMed ID: 38411298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive epigenetic regulation loop between AR and NSUN2 promotes prostate cancer progression.
    Zhu W; Wan F; Xu W; Liu Z; Wang J; Zhang H; Huang S; Ye D
    Clin Transl Med; 2022 Sep; 12(9):e1028. PubMed ID: 36169095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The m
    Li P; Wang W; Zhou R; Ding Y; Li X
    Clin Transl Med; 2023 Nov; 13(11):e1466. PubMed ID: 37983928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of m
    Wang X; Mao Y; Xu H; Chen J; Chen X
    Heliyon; 2023 Sep; 9(9):e19680. PubMed ID: 37809908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRDMT1-mediated RNA C-5 methylation as a novel target in anticancer therapy.
    Lewinska A; Adamczyk-Grochala J; Wnuk M
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188964. PubMed ID: 37625528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of interaction between verteporfin and yes-associated protein 1/transcriptional coactivator with PDZ-binding motif-TEA domain pathway on the progression of isocitrate dehydrogenase wild-type glioblastoma.
    Osama M; Essibayi MA; Osama M; Ibrahim IA; Nasr Mostafa M; Şakir Ekşi M
    J Cent Nerv Syst Dis; 2023; 15():11795735231195760. PubMed ID: 37600236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SKIL/SnoN attenuates TGF-β1/SMAD signaling-dependent collagen synthesis in hepatic fibrosis.
    Chi C; Liang X; Cui T; Gao X; Liu R; Yin C
    Biomol Biomed; 2023 Nov; 23(6):1014-1025. PubMed ID: 37389959
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.